Assessing BridgeBio Pharma (BBIO) Valuation After Recent Share Price Strength And Late Stage Pipeline Focus [Yahoo! Finance]
BridgeBio Pharma, Inc. (BBIO)
Last bridgebio pharma, inc. earnings: 3/2 08:29 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Why BridgeBio Pharma (BBIO) is on investors' radar today BridgeBio Pharma (BBIO) has been drawing attention as investors weigh its current share price of $74.14 against its recent performance and fundamentals in the rare disease and genetic medicine space. See our latest analysis for BridgeBio Pharma. The 1 day share price return of 3.07% comes after a mixed few months, with a 12.95% 1 month share price return contrasted against a weaker year to date move. At the same time, the 1 year total shareholder return of 125.49% and 3 year total shareholder return of almost 4x highlight strong longer term momentum. If BridgeBio's run in genetic medicines has your attention, this can be a good moment to see what else is moving in healthcare related AI, starting with 34 healthcare AI stocks With the stock at $74.14, a value score of 2, and both analyst targets and intrinsic estimates pointing higher, you have to ask: is BridgeBio still undervalued, or is the market already pricing in
Show less
Read more
Impact Snapshot
Event Time:
BBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BBIO alerts
High impacting BridgeBio Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
BBIO
News
- BridgeBio Pharma (BBIO) was upgraded by Royal Bank Of Canada to "moderate buy".MarketBeat
- BridgeBio Pharma (BBIO) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $100.00 price target on the stock.MarketBeat
- Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 – Here's Why [Yahoo! Finance]Yahoo! Finance
- Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54GlobeNewswire
- BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9 [Yahoo! Finance]Yahoo! Finance
BBIO
Earnings
- 2/24/26 - Miss
BBIO
Sec Filings
- 4/16/26 - Form SCHEDULE
- 4/13/26 - Form 4
- 4/9/26 - Form 144
- BBIO's page on the SEC website